Dyadic Logo Current.jpg
Dyadic to Present at Upcoming Events
May 03, 2021 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...
Dyadic Logo Current.jpg
Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”
April 22, 2021 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on developing and...
Dyadic Logo Current.jpg
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
March 18, 2021 08:30 ET | Dyadic International, Inc.
Israel Institute for Biological Research (IIBR) reports successful challenge studies using human ACE2 transgenic mice vaccinated with SARS-CoV-2-S-RBD vaccine candidate manufactured from...
logo-dark.png
Aegis Sciences Announces CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
March 16, 2021 09:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., March 16, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services,...
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
March 10, 2021 10:00 ET | Codex
San Diego, March 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The...
106 COVID VARIANTS IDENTIFIED IN 12 U.S. STATES
March 09, 2021 12:19 ET | MAKO Medical
Raleigh, North Carolina, March 09, 2021 (GLOBE NEWSWIRE) -- RALEIGH, NORTH CAROLINA [March 9, 2021]— MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing,...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Study for STI-2099 (Intranasal COVIDROPS) in Healthy Volunteers and Outpatient Treatment for Newly Diagnosed COVID-19 Positive Patients
March 02, 2021 16:02 ET | Sorrento Therapeutics, Inc.
FDA granted IND clearance today for the commencement of a Phase 1 safety and pharmacokinetic study for STI-2099 (COVIDROPS™) in healthy volunteers and outpatients with mild COVID-19 disease with or...
MAKO MEDICAL RELEASES LATEST COVID-19 VARIANT DATA
February 16, 2021 11:39 ET | MAKO Medical
Raleigh, North Carolina, Feb. 16, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, released new information regarding the company's...
admera_health_final_logo_transparent_final.jpg
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
June 26, 2018 09:13 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus...
ARUP Laboratories and PierianDx Create Partnership to Produce More Efficient and Effective Diagnostic Genetic Tests
November 12, 2014 17:22 ET | ARUP Laboratories
ST. LOUIS and SALT LAKE CITY, Nov. 12, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories and PierianDx announced today a partnership that will result in faster and more efficient diagnostic genetic testing...